Tamai M - Search Results

1

Clinical and immunological evaluation of intraoperative radiation therapy for patients with unresectable pancreatic cancer.

Yamaue H, Tanimura H, Aoki Y, Tsunoda T, Iwahashi M, Tani M, Tamai M, Noguchi K, Kashiwagi H, Sasaki M, et al. Yamaue H, et al. Among authors: tamai m. J Surg Oncol. 1992 Jan;49(1):10-5. doi: 10.1002/jso.2930490104. J Surg Oncol. 1992. PMID: 1548874

2

Enhancement of tumor cell susceptibility to lymphokine-activated killer cells by treatment with the streptococcal preparation OK432.

Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Tamai M, Noguchi K, Hotta T, Arii K. Yamaue H, et al. Among authors: tamai m. Biotherapy. 1992;5(1):83-93. doi: 10.1007/BF02194788. Biotherapy. 1992. PMID: 1389905

3

Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients.

Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Tamai M, Noguchi K, Hotta T. Iwahashi M, et al. Among authors: tamai m. Int J Cancer. 1992 Apr 22;51(1):67-71. doi: 10.1002/ijc.2910510114. Int J Cancer. 1992. PMID: 1532952

4

In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.

Tani M, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tamai M, Noguchi K, Arii K. Tani M, et al. Among authors: tamai m. Eur J Clin Pharmacol. 1992;42(6):623-7. doi: 10.1007/BF00265926. Eur J Clin Pharmacol. 1992. PMID: 1623902

5

Cisplatin treatment renders tumor cells more susceptible to attack by lymphokine-activated killer cells.

Yamaue H, Tanimura H, Noguchi K, Iwahashi M, Tsunoda T, Tani M, Tamai M, Hotta T, Mizobata S, Arii K. Yamaue H, et al. Among authors: tamai m. J Clin Lab Immunol. 1991 Aug;35(4):165-70. J Clin Lab Immunol. 1991. PMID: 1668852

6

Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes.

Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Tamai M, Inoue M. Yamaue H, et al. Among authors: tamai m. Biotherapy. 1990;2(3):247-59. doi: 10.1007/BF02173526. Biotherapy. 1990. PMID: 1698423

7

Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Noguchi K, Arii K, Hotta T. Tsunoda T, et al. Among authors: tamai m. Nihon Geka Hokan. 1991 Nov 1;60(6):396-405. Nihon Geka Hokan. 1991. PMID: 1820012

8

Clinical evaluation of chemotherapy under angiotensin II-induced hypertension in patients with advanced cancer.

Yamaue H, Tanimura H, Terashita S, Iwahashi M, Tani M, Tsunoda T, Tamai M, Mori K. Yamaue H, et al. Among authors: tamai m. Nihon Geka Hokan. 1990 Jul 1;59(4):302-9. Nihon Geka Hokan. 1990. PMID: 2130794

9

[Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes].

Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Inoue M, Tamai M. Yamaue H, et al. Among authors: tamai m. Nihon Gan Chiryo Gakkai Shi. 1990 May 20;25(5):978-89. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2391445 Japanese.

10

Augmentation of lymphokine-activated killer cell activity by lentinan.

Tani M, Tanimura H, Yamaue H, Tsunoda T, Iwahashi M, Noguchi K, Tamai M, Hotta T, Mizobata S. Tani M, et al. Among authors: tamai m. Anticancer Res. 1993 Sep-Oct;13(5C):1773-6. Anticancer Res. 1993. PMID: 8267381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

912 results

Search Page

Filters